Bright Minds Biosciences Inc (DRUG) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.00x
Bright Minds Biosciences Inc (DRUG) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $240.16K. See Bright Minds Biosciences Inc (DRUG) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$240.16K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Bright Minds Biosciences Inc (None–None)
Year-by-year capital reinvestment analysis for Bright Minds Biosciences Inc. See DRUG FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow